Positioning Intelligence

Short Interest Intelligence

Reported short interest, days to cover, price reaction, sector pressure, squeeze risk, bearish conviction, and where positioning is fighting the tape.

Latest settlement 30 Jun 2026 Updated 12 Jul 2026 12:36

Signal Design

Not just “high short interest”

We score the latest reported short position against its own history, then compare that crowding with days to cover, price movement since the prior report, and Sharemaestro trend context. The result is a research map, not a trade recommendation.

The aim is to show where positioning is crowded, confirmed, trapped, or unwinding, so the user can build a better shortlist before doing ticker-level work.

Squeeze PressureShorts are crowded while price or trend is improving.
Bearish ConvictionShorts are adding while price action confirms weakness.
DivergenceShort positioning and price action are disagreeing.
CoveringShorts are reducing exposure as price rises.
Reset

Setup Distribution

classification mix
Neutral2001 names
Squeeze Pressure1264 names
Crowded Short1168 names
Bearish Conviction418 names
Positioning Divergence191 names
Covering Rally45 names

Positioning Map

short positioning versus price reaction
Shorts under pressureShort positioning increased while price rose.
1718
Shorts being confirmedShort positioning increased while price weakened.
1121
Covering into strengthShort positioning fell while price rose.
1124
Bearish pressure easingShort positioning fell while price also weakened.
1113

Radar Table

Current Short-Interest Reads

Showing 31-60 of 418
StockSetupScoreShort interestChangeDays coverPrice reactionTrend
TCRTAlaunos Therapeutics Inc Bearish Conviction 90 14.7K +26.4% 1.05 -8.0% Weak
FSLYFastly, Inc. Class A Common Stock Bearish Conviction 89 25.4M +35.8% 4.41 -7.8% Weak
VIOTViomi Technology ADR Bearish Conviction 89 168.3K +58.6% 1.36 -13.0% Weak
FUFUBitFuFu Inc. Class A Ordinary Shares Bearish Conviction 89 232.7K +64.3% 1.00 -7.5% Weak
VIVSVivoSim Labs, Inc. Bearish Conviction 89 113.9K +470.4% 1.00 -9.6% Weak
LXULsb Industries Inc Bearish Conviction 89 3.1M +15.1% 3.32 -11.1% Weak
AFJKAimei Health Technology Co., Ltd Ordinary Share Bearish Conviction 89 4.2K +94.5% 1.00 -18.8% Weak
BIDUBaidu Inc Bearish Conviction 89 11.7M +35.9% 5.29 -10.0% Weak
ARTLArtelo Biosciences Inc Bearish Conviction 88 195.9K +43.4% 1.00 -17.6% Weak
PANLPangaea Logistic Bearish Conviction 88 1.3M +25.3% 1.84 -11.2% Weak
DOWDow Inc Bearish Conviction 88 34.8M +13.6% 2.47 -14.2% Weak
LSHLakeside Holding Limited Common Stock Bearish Conviction 88 112.1K +390.0% 1.00 -13.3% Weak
BIAFbioAffinity Technologies, Inc. Bearish Conviction 87 816.6K +124.8% 1.00 -43.9% Weak
CNTXContext Therapeutics Inc Bearish Conviction 87 3.2M +275.7% 1.00 -58.3% Weak
MMLPMartin Midstream Partners LP Bearish Conviction 87 105.4K +29.6% 2.13 -21.0% Weak
TCTuanChe ADR Bearish Conviction 87 27.1K +384.4% 1.00 -18.3% Weak
VEEAVeea Inc. Bearish Conviction 87 1.0M +152.4% 1.00 -27.2% Weak
YRDYirendai Ltd Bearish Conviction 87 172.6K +45.8% 1.54 -5.9% Weak
VGVenture Global, Inc. Bearish Conviction 87 43.6M +10.0% 3.17 -16.2% Weak
GDEVGDEV Inc. Bearish Conviction 87 7.2K +32.8% 3.55 -5.5% Weak
CODACoda Octopus Group Inc Bearish Conviction 86 232.5K +18.9% 1.14 -12.1% Weak
TWTradeweb Markets Inc Bearish Conviction 86 3.6M +18.9% 1.99 -7.6% Weak
NRTNorth European Oil Royalty Trust Bearish Conviction 86 51.6K +27.6% 1.55 -5.2% Weak
CVKDCadrenal Therapeutics, Inc. Common Stock Bearish Conviction 86 82.0K +13.5% 1.21 -17.6% Weak
MSCStudio City International Holdings Ltd Bearish Conviction 86 5.8K +47.4% 1.00 -20.8% Weak
JFBJFB Construction Holdings Class A Common Stock Bearish Conviction 86 981.3K +43.0% 2.52 -7.1% Weak
PLTRPalantir Technologies Inc. Bearish Conviction 86 87.3M +14.2% 1.87 -11.8% Weak
CNFCNFinance Holdings Ltd Bearish Conviction 86 2.6K +35.2% 1.00 -7.6% Weak
SSLSasol Ltd Bearish Conviction 86 4.9M +17.3% 2.42 -25.6% Weak
AAPGAscentage Pharma Group International Bearish Conviction 86 158.0K +20081.7% 5.20 -4.7% Weak

Short interest is delayed, reported twice monthly, and shown for educational research only. It does not prove buyer or seller intent, and it is not financial advice.